Hypertension, type 2 diabetes contribute to brain changes in Puerto Rican seniors
Apr 01, 2022
A high prevalence of hypertension and type 2 diabetes was seen among the Puerto Rican cohort; those with both have deteriorating patterns in major white matter tracts.
House passes bill to limit insulin costs to $35 a month
Apr 01, 2022
The bill now has to pass the Senate with at least 10 Republican votes.
GLP-1 RA use may up risk for gallbladder, biliary diseases
Mar 31, 2022
Treatment with GLP-1 RA, used for diabetes and weight loss, was linked to an increased risk, especially in trials for weight loss, and with higher doses and longer duration of use.
Risk, burden of diabetes up after acute SARS-CoV-2 infection
Mar 30, 2022
The risks and burdens of postacute outcomes increased in graded manner based on COVID-19 severity.
Overtreatment of T2DM common among VA nursing home residents
Mar 25, 2022
A minority of those overtreated or potentially overtreated have their medication regimens appropriately deintensified.
Timing, type of food intake linked to mortality risks in diabetes
Mar 24, 2022
Among people with diabetes, higher intake of processed meat in the evening linked to increased risk for CVD mortality
6 percent with prediabetes develop diabetes within one year
Mar 11, 2022
Diabetes development is more likely for those with higher glycemic level, a BMI ≥30 kg/m2 and among Black versus white individuals.
Lipid profiling can predict future risk for type 2 diabetes, CVD
Mar 11, 2022
In the highest-risk groups for T2D and CVD, significantly altered lipidome compositions affected 167 and 157 lipid species, respectively.
These medical innovations are good news for aging adults
By
Lois A. Bowers
Mar 07, 2022
Sepsis, prostate cancer, high cholesterol, type 2 diabetes, hypertension. These are some of the conditions that will benefit from medical advancements noted on the Cleveland Clinic’s recently announced...
Newly diagnosed diabetes at COVID-19 admission profiled
Mar 02, 2022
Lower levels of glucose and HbA1c, and higher levels of inflammatory markers, were seen in COVID-19 patients with newly diagnosed diabetes mellitus versus preexisting diabetes.